Stay updated with breaking news from Eric Leire. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
22.06.2023 - Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that all the resolutions submitted to a vote at the Combined General Shareholders’ Meeting were approved as proposed by OSE Immunotherapeutics’ Board of ... Seite 1
Genflow Biosciences PLC on Tuesday said it began trading on the OTCQB Venture Market in the US, in addition to its London Stock Exchange Main Market listing. The London-based biotechnology company... | June 13, 2023
31.05.2023 - Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that the Board of Directors, upon the proposal of the Nomination and Remuneration Committee, has proposed Eric Leire, MD, as an independent Director of the ... Seite 1
Genflow Biosciences PLC (LSE:GENF) CEO Dr Eric Leire spoke to Proactive after releasing final results for calendar year 2022 that show that the UK-based...
Genflow Biosciences PLC shares jumped on Wednesday, after it said it has submitted an application for trading of its shares on the OTCQB Venture Market in the US. Genflow is a London-based... | April 19, 2023